Although gene expression-based clustering was able to validate the IRX/HOXA axis as a substructure of KMT2A-r infant ALL, in order to reveal more refined disease subgroups, we further analyzed the same 61 infant leukemia samples with DNA methylation array. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.